New allergy nasal spray good for eye symptoms
Newly approved Veramyst, a nasal spray containing fluticasone furoate, will not only improve nasal symptoms associated with allergies but also relieve allergic eye symptoms, according to manufacturer GlaxoSmithKline.
Newly approved Veramyst, a nasal spray containing fluticasone furoate, will not only improve nasal symptoms associated with allergies but also relieve allergic eye symptoms, according to manufacturer GlaxoSmithKline. The product is approved by the FDA for treating seasonal and perennial allergy symptoms in adults and children two years of age and older. Specifically, the spray has been shown to relieve nasal congestion; sneezing; runny, itchy nose; and red, itchy, and watery eyes. Veramyst will be available nationwide by late May 2007 and contains 27.5 mcg fluticasone furoate per 50-microliter spray. Each 10-gm bottle contains 120 sprays.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
